Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
October 23, 2023
In times of mounting debt, the quest for universal health coverage (UHC) faces critical challenges. Rising debt has far-reaching effects, including reduced access to financing, political instability, and decreased spending on international aid. The burden of debt, coupled with high inflation, is thr...
CASE STUDIES
June 01, 2023
For the last three decades, Zambia has implemented a series of policies to gradually work towards Universal Health Coverage (UHC). This case study delves into the process followed by the government of Zambia in developing those policies, with the aim of supporting other countries embarking on the jo...
Blog Post
May 08, 2023
Countries moving towards universal health coverage (UHC) face challenging decisions about what benefits they will include and cover—especially in the current fiscal and economic climate. Countries need easy-to-use and comprehensive tools to help them think through the path to expand (or contract) be...
POLICY PAPERS
May 08, 2023
Countries moving towards universal health coverage are challenged about what new health benefits and interventions they will add to their national health programs. We propose a new framework organized in three layers that outlines the features or characteristics to consider when designing and buildi...
Blog Post
March 07, 2023
The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 12, 2022
On December 12, we celebrate countries’ efforts towards achieving Universal Health Coverage (UHC) and remind leaders of the importance of UHC and their promise of #HealthForAll. Yet this year, World UHC Day takes place against a backdrop of significant fiscal pressure stemming from changing economic...
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...